Shares of cruise operators rallied Monday, as the Food and Drug Administration's full approval of the COVID-19 vaccine developed by Pfizer Inc.
PFE,
+2.38%
and partner BioNTech SE
BNTX,
+10.74%
boosted hopes for increased vaccination rates. Carnival Corp.'s stock
CCL,
+3.44%
ran up 2.6%, Norwegian Cruise Line Holdings Ltd.
NCLH,
+3.45%
shares climbed 3.0% and Royal Caribbean Group
GRP,
-0.42%
tacked on 1.1%. In comparison, the S&P 500
SPX,
+1.06%
advanced 0.9%. The companies have required its staff and guests on most of their cruises to be vaccinated. Acting FDA Commissioner Janet Woodcock said the FDA approval of the Pfizer-BioNTech vaccine "may now instill additional confidence to get vaccinated."